Are you Dr. Lorenzi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 15 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
50 Staniford St
3rd Floor S50 3 Diabetes Unit
Boston, MA 02114Phone+1 617-726-8722Fax+1 617-724-8534
Summary
- Dr. Mara Lorenzi, MD is a board certified pathologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is a Professor of Ophthalmology at Schepens Eye Research Institute.
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 1973 - 1976
University of Torino Faculty of MedicineClass of 1971
Certifications & Licensure
MA State Medical License 1988 - 2013- American Board of Pathology Clinical Pathology
Clinical Trials
- Retinal Blood Flow and Microthrombi in Type 1 Diabetes Start of enrollment: 2003 Jun 01
Publications & Presentations
PubMed
- 284 citationsThe polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient.Mara Lorenzi
Experimental Diabetes Research. 2007-07-26 - 26 citationsCushing's disease: growth hormone response to hypoglycemia after correction of hypercortisolism.J B Tyrrell, Jeanine P. Wiener-Kronish, Mara Lorenzi, R.M. Brooks, Peter H. Forsham
The Journal of Clinical Endocrinology and Metabolism. 1977-01-01 - 77 citationsNormalization of fasting hyperglucagonemia and excessive glucagon responses to intravenous arginine in human diabetes mellitus by prolonged infusion of insulin.John E. Gerich, Eva Tsalikian, Mara Lorenzi, Victor Schneider, Nancy J. V. Bohannon
The Journal of Clinical Endocrinology and Metabolism. 1975-12-01
Press Mentions
Doctors Use Growth Factor to Protect the Retina in DiabeticsFebruary 2nd, 2017
Growth Factor Shown to Protect the Retina in Early Stage DiabetesFebruary 2nd, 2017
Researchers Identify Candidate Biomarker of Accelerated Onset Diabetic RetinopathyApril 1st, 2016
